contact@tendernotify.co.uk
Back to suppliers

ACCORD-UK LTD

Total awarded
£1,708,458,184
NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
15 Jun 2026 £166,347,397
SARS-CoV-2 Adult Vaccine Supply (2026)
10 Jun 2026 £1
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
01 Jun 2026 £813,863,584
NHS National Generics Pharmaceuticals - Supply Chain Resilience
01 May 2026 £35,010,320
NHS National Branded Interim - 1 June 2026
10 Apr 2026 £529,090,780
NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide
24 Mar 2026 £19,595,208
Generic Drugs – Injections/Infusions 2
03 Mar 2026 £5,857,450
NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
25 Feb 2026 £14,758,000
Transitional Drugs 6
29 Jan 2026 £1,637,728
NHS National Generic Pharmaceuticals - Wave 15c
13 Jan 2026 £37,160,000
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
25 Nov 2025 £25,881,000
NHS National Framework for Generics Housekeeping
10 Nov 2025 £21,562,716
Project/Contract NHS National Framework for Denosumab Injection
30 Sep 2025 £37,694,000
Generic, Branded Generic & Proprietary Medicinal Products - Group 18
SARS-CoV-2 Adult Vaccine Supply (2026)
NP36126 Antibiotic & Genito Urinary Medicines
NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines
NHS National Framework for Transition products (Nilotinib and Ticagrelor)
NP30925 Psychiatry and Neurology Medicines